| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers H > Headlines for HSBC USA Inc. > News item |
HSBC plans three-year return enhanced notes linked to three stocks
By Susanna Moon
Chicago, Feb. 26 - HSBC USA Inc. plans to price 0% return enhanced notes due March 1, 2017 linked to a basket of three equally weighted stocks, according to an FWP filing with the Securities and Exchange Commission.
The underlying companies are AstraZeneca plc, Bristol-Myers Squibb Co. and Merck & Co., Inc.
The payout at maturity will be par plus 176% of any gain in the basket.
Investors will be exposed to any losses.
HSBC Securities (USA) Inc. is the underwriter, and J.P. Morgan Securities LLC is the agent.
The notes will price on Feb. 28 and settle on March 5.
The Cusip number is 40432XU74.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.